Welcome to our dedicated page for Conmed news (Ticker: CNMD), a resource for investors and traders seeking the latest updates and insights on Conmed stock.
CONMED Corporation (NASDAQ: CNMD) news coverage tracks developments from this medical device manufacturer serving orthopedic surgeons, general surgeons, and other surgical specialists worldwide. The company produces surgical instruments, powered equipment, and patient monitoring devices used in operating rooms and ambulatory surgery centers.
CONMED news typically includes quarterly and annual earnings reports detailing revenue performance across its orthopedic and general surgery product lines. The company reports results that break down performance by geographic region and product category, providing insight into procedure volume trends and market share dynamics in the competitive medical device sector.
Beyond financial performance, CONMED announcements cover product launches and FDA clearances for new surgical devices, strategic decisions regarding product portfolio focus, and changes to the company's board of directors and executive leadership. The company also announces quarterly dividend declarations, reflecting its approach to returning capital to shareholders.
Medical device companies like CONMED operate in a regulated environment where new product introductions require extensive clinical validation and regulatory approval. News regarding the company's product development pipeline and regulatory submissions can signal future revenue opportunities. Additionally, announcements about manufacturing operations, acquisitions, and divestitures provide context for understanding the company's strategic direction within the surgical device market.
CONMED (NYSE: CNMD) is set to release its financial results for the second quarter of 2024 on July 31, 2024, after the market close. A conference call to discuss these results will be hosted by the company's management at 4:30 p.m. ET on the same day. Investors can participate in the conference call by pre-registering to obtain the dial-in number and passcode. The call will also be webcast live on the 'Investors' section of CONMED's website, with a replay available approximately one hour after the call ends.
CONMED (NYSE: CNMD) announced that Curt R. Hartman, Chair of the Board, President, and CEO, along with Todd W. Garner, Executive VP and CFO, will participate in a fireside chat at the Jefferies Global Healthcare Conference. The event is scheduled for 8:00 a.m. ET on June 6, 2024.
A live webcast will be accessible via the company's website and will be available for replay following the event.
CONMED (NYSE: CNMD) has announced a quarterly cash dividend of $0.20 per share. The announcement was made on May 22, 2024, and the dividend will be payable on July 5, 2024. Shareholders of record as of June 14, 2024, will be eligible to receive this dividend. This decision reflects the company's ongoing commitment to returning value to its shareholders.
CONMED (NYSE: CNMD) will be presenting at the BofA Securities Healthcare Conference with top executives discussing the company's future on May 14, 2024. The event will be live-streamed on the company's website for investors to access.
FAQ
What is the current stock price of Conmed (CNMD)?
What is the market cap of Conmed (CNMD)?
